Twist Bioscience Corp’s recent filing unveils that its Officer Cho Dennis acquired Company’s shares for reported $3147.0 on Jun 16 ’25. In the deal valued at $33.48 per share,94 shares were bought.
Then, Cho Dennis sold 257 shares, generating $8,160 in total proceeds. Upon selling the shares at $31.75, the insider now owns 105,061 shares.
Before that, Green Paula sold 853 shares. Twist Bioscience Corp shares valued at $27,083 were divested by the SVP of Human Resources at a price of $31.75 per share. As a result of the transaction, Green Paula now holds 127,895 shares, worth roughly $4.48 million.
Wolfe Research initiated its Twist Bioscience Corp [TWST] rating to an Outperform in a research note published on December 13, 2024; the price target was $60. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Goldman also remained covering TWST and has increased its forecast on January 17, 2024 with a “Buy” recommendation from previously “Neutral” rating. Berenberg started covering the stock on September 27, 2023. It rated TWST as “a Buy”.
Price Performance Review of TWST
On Monday, Twist Bioscience Corp [NASDAQ:TWST] saw its stock jump 4.53% to $35.04. Over the last five days, the stock has gained 5.04%. Twist Bioscience Corp shares have fallen nearly -24.60% since the year began. Nevertheless, the stocks have fallen -33.18% over the past one year. While a 52-week high of $60.90 was reached on 01/24/25, a 52-week low of $27.12 was recorded on 05/23/25.
Levels Of Support And Resistance For TWST Stock
The 24-hour chart illustrates a support level at 33.49, which if violated will result in even more drops to 31.95. On the upside, there is a resistance level at 35.87. A further resistance level may holdings at 36.70.
The most recent change occurred on January 05, 2023 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating along with a $33 price target.
